HealthPhase 3 Trial Reports Longer Survival With Arcotatug TavatecanBy Naomi CalderOct 23, 2026, 8:39 PM UTC
HealthMyeloma Foundation Launches U.S. Trial Network With Johnson & JohnsonBy Naomi CalderOct 22, 2026, 10:15 PM UTC
HealthBioNTech Plans Trodelvy Combination in Global Phase 3 Breast Cancer TrialBy Naomi CalderOct 22, 2026, 7:35 PM UTC
HealthResearcher Says Guinea-Bissau Newborn Hepatitis B Trial Will Not ProceedBy Naomi CalderOct 22, 2026, 3:16 AM UTC
HealthXBiotech Reports 12-Month Survival Threshold in TASKIN Cancer TrialBy Naomi CalderOct 19, 2026, 9:34 PM UTC
HealthTLC Reports Lower Pain and Opioid Use Than Exparel in Phase 3 TrialBy Naomi CalderOct 19, 2026, 4:45 PM UTC
HealthIDEAYA Shares Darovasertib Findings From Three Uveal Melanoma StudiesBy Naomi CalderOct 19, 2026, 4:44 PM UTC
HealthOculis Completes Randomization in Dry-Eye Trial With 176 EnrolledBy Naomi CalderOct 19, 2026, 11:05 AM UTC
